For the year ending 2025-12-31, NEO made $727,332K in revenue. -$108,025K in net income. Net profit margin of -14.85%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Net revenue | 727,332 | |||
| Cost of revenue | 413,039 | |||
| Gross margin | 314,293 | |||
| General and administrative | 273,337 | |||
| Research and development | 37,077 | |||
| Sales and marketing | 92,007 | |||
| Restructuring charges | 0 | |||
| Impairment charges (note 3 and note 7) | 27,753 | |||
| Total operating expenses | 430,174 | |||
| Loss from operations | -115,881 | |||
| Interest income | 9,070 | |||
| Interest expense | 3,753 | |||
| Other (income) expense, net | 296 | |||
| Loss before taxes | -110,268 | |||
| Income tax benefit | -2,243 | |||
| Net loss | -108,025 | |||
| Basic (in shares) | 128,101,000 | |||
| Diluted (in shares) | 128,101,000 | |||
NEOGENOMICS INC (NEO)
NEOGENOMICS INC (NEO)